Intracorporeal Lithotripters Market Insights Video

According to Cognitive Market Research, the global Intracorporeal Lithotripter market size is USD 815.2 million in 2024. It will expand at a compound annual growth rate (CAGR) of 4.50% from 2024 to 2031.

• North America held the major market share for more than 40% of the global revenue with a market size of USD 326.0 million in 2024 and will grow at a compound annual growth rate (CAGR) of 2.7% from 2024 to 2031.
• Europe accounted for a market share of over 30% of the global revenue with a market size of USD 244.56 million.
• Asia Pacific held a market share of around 23% of the global revenue with a market size of USD 187.50 million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.5% from 2024 to 2031.
• Latin America had a market share for more than 5% of the global revenue with a market size of USD 40.76 million in 2024 and will grow at a compound annual growth rate (CAGR) of 3.9% from 2024 to 2031.
• Middle East and Africa had a market share of around 2% of the global revenue and was estimated at a market size of USD 16.30 million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.2% from 2024 to 2031.
• Hospitals held the highest Intracorporeal Lithotripter market revenue share in 2024.